Body mass index is closely correlated to incident diabetes in patients with heart failure or myocardial infarction
暂无分享,去创建一个
C. Torp‐Pedersen | L. Køber | S. Z. Abildstrøm | J. Olesen | C. Andersson | M. Schmiegelow | S. Z. Abildstrom
[1] C. Torp‐Pedersen,et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. , 2004, Journal of the American College of Cardiology.
[2] S. Solomon,et al. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial , 2004, Circulation.
[3] V. Gudnason,et al. Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study , 2005, European Journal of Cardiovascular Prevention & Rehabilitation.
[4] P. Poole‐Wilson,et al. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) , 2007, Heart.
[5] S. Ball,et al. The incomplete Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) , 2002, European journal of heart failure.
[6] Matteo Anselmino,et al. Diabetes, prediabetes and cardiovascular risk , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[7] D. Tanné,et al. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. , 2005, European heart journal.
[8] G. Fonarow,et al. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. , 2010, Journal of the American College of Cardiology.
[9] L. Køber,et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. , 2000, European heart journal.
[10] A. Ahlbom,et al. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP) , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[11] M. Osler,et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. , 2003, Journal of clinical epidemiology.
[12] A. Vaag,et al. Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People , 2008, Circulation.
[13] L. Køber,et al. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. , 2008, European heart journal.
[14] K. Dickstein,et al. A randomised trial of a pre‐synaptic stimulator of DA2‐dopaminergic and α2‐adrenergic receptors on morbidity and mortality in patients with heart failure , 2008, European journal of heart failure.
[15] P. Andersen,et al. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. , 1992, Cardiology.
[16] Hirofumi Makino,et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] M. Mosller. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies , 1997, Clinical cardiology.